1. Home
  2. GPGI vs PTGX Comparison

GPGI vs PTGX Comparison

Compare GPGI & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GPGI

GPGI Inc.

N/A

Current Price

$16.36

Market Cap

5.0B

Sector

N/A

ML Signal

N/A

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$105.73

Market Cap

5.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPGI
PTGX
Founded
2000
2006
Country
United States
United States
Employees
977
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
5.2B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
GPGI
PTGX
Price
$16.36
$105.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
13
Target Price
N/A
$108.23
AVG Volume (30 Days)
3.3M
689.5K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
0.06%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$768.10
$873.97
Revenue Next Year
$126.25
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.48
$41.29
52 Week High
$25.66
$107.84

Technical Indicators

Market Signals
Indicator
GPGI
PTGX
Relative Strength Index (RSI) 40.87 59.17
Support Level $15.48 $76.63
Resistance Level $18.83 $107.84
Average True Range (ATR) 0.87 3.88
MACD 0.19 -0.11
Stochastic Oscillator 41.27 83.00

Price Performance

Historical Comparison
GPGI
PTGX

About GPGI GPGI Inc.

GPGI Inc is a diversified holding permanent capital platform designed to acquire, own, and scale high-quality businesses that hold great positions in good industries.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

Share on Social Networks: